People with type 2 diabetes often face an overly complex and confusing environment as they learn to manage their condition. Device and supply distributors can leverage their underutilized points of contact to provide services and support to patients.
The company has $20 million in funding, including $16 million from a Series A funding round announced Wednesday, and backing from the veteran health executive who has already been at the helm of two startups-turned-unicorns.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Senseonics' FDA-approved CGM has a sensor that lasts six months, a first for any CGM. Other competing solutions from Medtronic and Dexcom last anywhere between three to 10 days.
Verily’s virtual diabetes platform, Onduo, is expanding to support additional conditions and languages, Onduo’s CEO Vindell Washington shared. How will the company differentiate itself among a growing number of multi-condition platforms, such as Livongo and Omada?
The insurer picked digital health startup Vida to offer a virtual diabetes management program for Medicaid patients in Kentucky.
The company is rolling out Level2, a digital health program for patients with type 2 diabetes. It uses wearable devices and coaches to help users manage their health.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Bigfoot Biomedical plans to submit an application to the FDA for clearance of its smart insulin pen caps this month. The devices pull in information from a connected glucose monitor to help users calculate the optimal insulin with each meal.
Eventually, Fruit Street plans to develop a more holistic telemedicine solution that will include behavioral health with psychiatrists and psychologists via live video, virtual primary care, in addition to the dietitian-based services it currently offers.
Check out new developments from healthcare startups across primary care, women's health, diabetes management and digital health.
The Centers for Disease Control and Prevention found that diabetes-related blindness costs can total more than $500 million per year, but eye care screenings are one of the easiest and most cost-effective ways to detect diabetes early and get patients the treatment they need.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Publicly-traded DarioHealth plans to use the cash to put its smartphone-based glucometer into the hands of insurers.
The PBM selected 15 programs to offer on its first digital health formulary, starting in January 2020.
As we close out November, the National Diabetes Month, here are three best practices health plans can use to motivate members to complete the diabetic activities that are critical to their health.
Patients who also had another chronic disease, were using insulin daily to manage their Type 2 Diabetes or had lived with diabetes for more than two years were more likely to have a positive effect on empowerment measurements.
Through the collaboration, Hello Heart will offer its customers LifeScan's OneTouch line of connected glucose monitors and test strips which can upload results automatically onto the company's platform.